These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 39004156)
21. Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Vazquez-Roque MI; Camilleri M; Smyrk T; Murray JA; O'Neill J; Carlson P; Lamsam J; Eckert D; Janzow D; Burton D; Ryks M; Rhoten D; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1262-9. PubMed ID: 23042942 [TBL] [Abstract][Full Text] [Related]
22. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. Annaházi A; Ferrier L; Bézirard V; Lévêque M; Eutamène H; Ait-Belgnaoui A; Coëffier M; Ducrotté P; Róka R; Inczefi O; Gecse K; Rosztóczy A; Molnár T; Ringel-Kulka T; Ringel Y; Piche T; Theodorou V; Wittmann T; Bueno L Am J Gastroenterol; 2013 Aug; 108(8):1322-31. PubMed ID: 23711626 [TBL] [Abstract][Full Text] [Related]
23. Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism. Barbaro MR; Di Sabatino A; Cremon C; Giuffrida P; Fiorentino M; Altimari A; Bellacosa L; Stanghellini V; Barbara G Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G439-47. PubMed ID: 26744473 [TBL] [Abstract][Full Text] [Related]
24. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome. Bednarska O; Walter SA; Casado-Bedmar M; Ström M; Salvo-Romero E; Vicario M; Mayer EA; Keita ÅV Gastroenterology; 2017 Oct; 153(4):948-960.e3. PubMed ID: 28711627 [TBL] [Abstract][Full Text] [Related]
25. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling. Mahurkar-Joshi S; Rankin CR; Videlock EJ; Soroosh A; Verma A; Khandadash A; Iliopoulos D; Pothoulakis C; Mayer EA; Chang L Gastroenterology; 2021 Jun; 160(7):2409-2422.e19. PubMed ID: 33617890 [TBL] [Abstract][Full Text] [Related]
26. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358 [TBL] [Abstract][Full Text] [Related]
27. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome. Sundin J; Nordlander S; Eutamene H; Alquier-Bacquie V; Cartier C; Theodorou V; Le Nevé B; Törnblom H; Simrén M; Öhman L Neurogastroenterol Motil; 2019 Nov; 31(11):e13701. PubMed ID: 31518490 [TBL] [Abstract][Full Text] [Related]
28. Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function. Peters SA; Edogawa S; Sundt WJ; Dyer RB; Dalenberg DA; Mazzone A; Singh RJ; Moses N; Smyrk TC; Weber C; Linden DR; MacNaughton WK; Turner JR; Camilleri M; Katzka DA; Farrugia G; Grover M Am J Gastroenterol; 2017 Jun; 112(6):913-923. PubMed ID: 28323272 [TBL] [Abstract][Full Text] [Related]
29. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome. Meira de-Faria F; Casado-Bedmar M; Mårten Lindqvist C; Jones MP; Walter SA; Keita ÅV Neurogastroenterol Motil; 2021 Nov; 33(11):e14130. PubMed ID: 33797165 [TBL] [Abstract][Full Text] [Related]
30. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice. Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929 [TBL] [Abstract][Full Text] [Related]
31. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094 [TBL] [Abstract][Full Text] [Related]
32. Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome. Keszthelyi D; Troost FJ; Jonkers DM; van Eijk HM; Lindsey PJ; Dekker J; Buurman WA; Masclee AA Aliment Pharmacol Ther; 2014 Aug; 40(4):392-402. PubMed ID: 24943480 [TBL] [Abstract][Full Text] [Related]
33. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Dothel G; Barbaro MR; Boudin H; Vasina V; Cremon C; Gargano L; Bellacosa L; De Giorgio R; Le Berre-Scoul C; Aubert P; Neunlist M; De Ponti F; Stanghellini V; Barbara G Gastroenterology; 2015 May; 148(5):1002-1011.e4. PubMed ID: 25655556 [TBL] [Abstract][Full Text] [Related]
34. Serum and colonic mucosal immune markers in irritable bowel syndrome. Chang L; Adeyemo M; Karagiannides I; Videlock EJ; Bowe C; Shih W; Presson AP; Yuan PQ; Cortina G; Gong H; Singh S; Licudine A; Mayer M; Tache Y; Pothoulakis C; Mayer EA Am J Gastroenterol; 2012 Feb; 107(2):262-72. PubMed ID: 22158028 [TBL] [Abstract][Full Text] [Related]
35. Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility. Guarino MP; Barbara G; Cicenia A; Altomare A; Barbaro MR; Cocca S; Scirocco A; Cremon C; Emerenziani S; Stanghellini V; Cicala M; Severi C Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27619727 [TBL] [Abstract][Full Text] [Related]
36. Impaired intestinal molecular tightness in the mucosa of irritable bowel syndrome: what are the mediators? Vicario M; Alonso C; Santos J Gut; 2009 Feb; 58(2):161-2. PubMed ID: 19136518 [No Abstract] [Full Text] [Related]
37. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012 [TBL] [Abstract][Full Text] [Related]
38. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice. Long Y; Du L; Kim JJ; Chen B; Zhu Y; Zhang Y; Yao S; He H; Zheng X; Huang Z; Dai N Neurogastroenterol Motil; 2018 Sep; 30(9):e13348. PubMed ID: 29644768 [TBL] [Abstract][Full Text] [Related]
39. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope]. Kong WM; Gong J; Dong L; Chen MX Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1167-70, 1172. PubMed ID: 17715017 [TBL] [Abstract][Full Text] [Related]
40. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Camilleri M; Lasch K; Zhou W Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G775-85. PubMed ID: 22837345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]